Analystreport

Kezar Life Sciences (NASDAQ:KZR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Kezar Life Sciences, Inc.  (KZR) 
Last kezar life sciences, inc. earnings: 8/7 04:05 pm Check Earnings Report